Two surface antigen targets for immunotoxin-mediated elimination of normal and neoplastic murine B cells.
Parkhouse
R M
RM
National Institute for Medical Research, London, U.K.
Santos-Argumedo
L
L
Teixeiral
C
C
Henry
R V
RV
Wawrzynczak
E
E
D000818:Animals; D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D000954:Antigens, Surface; D001402:B-Lymphocytes / Q000276:immunology*; D015815:Cell Adhesion Molecules; D000922:Immunotoxins / Q000494:pharmacology; D037102:Lectins; D016393:Lymphoma, B-Cell / Q000276:immunology* / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D012276:Ricin / Q000494:pharmacology; D051918:Sialic Acid Binding Ig-like Lectin 2
D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D000954:Antigens, Surface; C497868:Cd22 protein, mouse; D015815:Cell Adhesion Molecules; D000922:Immunotoxins; D037102:Lectins; D051918:Sialic Acid Binding Ig-like Lectin 2; D012276:Ricin